› Bone Tissue Scaffold Porosity & Mechanical Design Simulator Back
Regenerative Medicine

Bone Tissue Scaffold Porosity & Mechanical Design Simulator

Design the porous scaffolds used in bone tissue engineering. Adjust material, porosity and pore size and the tool updates the Gibson-Ashby effective modulus and strength, the Kozeny-Carman permeability and the cell-migration / angiogenesis indices in real time, helping you avoid stress shielding while keeping pores open for cell and vessel ingrowth.

Parameters
Scaffold material
Sets the bulk modulus E_s and strength σ_s
Porosity ε
%
Void volume / total volume. 70-85% is the bone-regeneration sweet spot
Mean pore size d
μm
100-500 μm optimum for osteoblast and vascular ingrowth
Strut diameter
μm
Wall thickness (limited by 3D-printing resolution)
Target bone type
Reference values for the matching ratio
Degradation time
weeks
Time for the scaffold to fully resorb in vivo
Vascularization rate
Relative coefficient for VEGF-driven vessel ingrowth
Results
—
Effective modulus (GPa)
—
Effective strength (MPa)
—
Bone match E (%)
—
Bone match σ (%)
—
Permeability (m²)
—
Cell migration idx
—
Porous scaffold — osteoblasts, angiogenesis and biodegradation animation

The blue mesh is the porous scaffold, green dots are osteoblasts and red lines are new vessels. The scaffold thins over the degradation time while new bone tissue fills the voids.

Effective modulus E_eff vs porosity ε
Material comparison (E_s and σ_s)
Theory & Key Formulas

$$\frac{E_{eff}}{E_s} = (1-\varepsilon)^2,\quad \frac{\sigma_{eff}}{\sigma_s} = 0.3(1-\varepsilon)^{3/2},\quad k = \frac{\varepsilon^3 d^2}{150(1-\varepsilon)^2}$$

Gibson-Ashby open-cell scaling and Kozeny-Carman permeability. ε: porosity, E_s/σ_s: bulk modulus/strength, d: pore size, k: permeability. Stiffness drops sharply with porosity while permeability rises with ε³.

$$\text{Match}_E = \frac{E_{eff}}{E_{bone}}\times 100\%,\quad \text{Match}_\sigma = \frac{\sigma_{eff}}{\sigma_{bone}}\times 100\%$$

Bone matching ratios. Close to 100% is ideal (no stress shielding). Below 20% means under-support; above 500% means likely bone resorption around the implant.

Bone scaffold porosity and mechanical design

🙋
In regenerative medicine they put something into a bone defect to help it heal, right? What exactly is a "scaffold"?
🎓
It is the central "support framework" in bone tissue engineering. After a major trauma or after a bone tumour is resected, the defect can be too large to fill with autograft. So you implant an artificial porous structure, and over months the patient's own osteoblasts and vessels invade it; eventually it is replaced by new bone. The scaffold has to do four jobs at once: (1) provide a surface for cells to attach to, (2) carry the load, (3) let vessels grow in, and (4) eventually disappear. All four in one structure.
🙋
70% porosity means it is basically empty. How does anything that void survive load?
🎓
Exactly the right question. This is the core tension in the field. You need 70-85% void to let vessels in — without vessels, cells more than a few hundred microns deep die. Now look at the left: Gibson-Ashby gives E_eff = E_s·(1-ε)². At 70% porosity the stiffness drops to (0.3)² = 9% of the bulk material. So a dense HA ceramic at 100 GPa lands around 9 GPa porous — slightly softer than cortical bone (17 GPa) and far stiffer than trabecular (0.4 GPa). It is exactly that "Goldilocks zone" that the material families in this tool target.
🙋
What is "stress shielding"? I hear about it with implants.
🎓
Critical concept. Bone needs to feel load to maintain itself (Wolff's law); remove the load and it atrophies. A dense Ti6Al4V implant (113 GPa) put in place of bone (17 GPa) takes essentially all the load — the surrounding bone goes "off duty" and resorbs. Long term that loosens the implant. The modern answer is porous titanium or biodegradable polymers tuned so the bulk stiffness matches bone. Try to find a combination where "Bone match E" sits between 80-120%.
🙋
You mentioned pore size matters too. Why specifically 100-500 μm?
🎓
Osteoblasts are 10-20 μm across, capillaries 5-10 μm. Below 50 μm the cells physically cannot enter. Above 100 μm migration and nutrient diffusion become workable, with 300-400 μm being where vessel invasion and new-bone formation peak in vivo studies. Above 500 μm the specific surface area collapses and cells have nothing to attach to. So "100-500 μm" became the rule of thumb. State-of-the-art 3D printing and TPMS (Gyroid, Schwarz) structures let you tune this band precisely. Stryker, Zimmer and Geistlich Bio-Oss are well-known clinical examples.
🙋
What about the degradation-time slider? Is faster better?
🎓
Tricky balance. The ideal is "degradation rate equals new-bone formation rate". Too fast and the scaffold disappears before bone forms, the defect collapses. Too slow and you get chronic inflammation that blocks bone maturation. PHBV resorbs over 1-2 years, PCL over 2-3, PLGA over 1-12 months depending on composition — match it to the defect (cranial heals in months, long bone in 1-2 years). HA and BCP slowly remodel over years. Ti6Al4V never degrades, so revision surgery may be needed eventually — which is exactly why biodegradable scaffolds are so actively researched.

Frequently Asked Questions

Bone tissue engineering generally recommends 70-85% porosity. This is the volume fraction required for cell attachment, nutrient supply, vascular invasion and new bone ingrowth. Below 50%, angiogenesis and cell migration are inhibited; above 95%, the Gibson-Ashby model gives an effective modulus less than 0.25% of the solid material, which cannot support physiological loads. Sliding ε in this tool simultaneously updates E_eff = E_s·(1-ε)² and σ_eff = 0.3·σ_s·(1-ε)^(3/2), and shows matching ratios against cortical, trabecular and craniofacial bone.
Pore sizes in the 100-500 μm range are optimal for osteoblast migration and attachment, and in vivo studies consistently show vascular invasion and new bone formation peaking around 300-400 μm. Below 100 μm cell migration becomes physically difficult; above 500 μm the specific surface area drops and cell-attachment sites are lost. The "cell migration index" here equals 1.0 between 100 and 500 μm and decreases linearly outside that band, as a simple first-pass design heuristic.
Stress shielding occurs when the scaffold is too stiff compared to surrounding bone: the bone no longer feels load and atrophies. A dense Ti6Al4V (E ≈ 113 GPa) implanted in cortical bone (E ≈ 17 GPa) is seven times stiffer and triggers long-term resorption. Raise the porosity to lower E_eff toward the bone target. At 70% porosity, Ti6Al4V drops to roughly 10 GPa, which matches cortical bone. For trabecular bone (0.4 GPa), biodegradable polymers such as PHBV or PCL are the first-choice candidates.
Ideally "degradation rate equals new-bone formation rate", matched to the repair time of the defect. Cranial defects target 6-12 months, long-bone defects 12-24 months. PHBV degrades in roughly 12-24 months, PCL in 24-36, and PLGA in 1-12 months depending on the L/G ratio. The degradation-time-in-weeks slider sets the timescale, and the canvas animation visualises scaffold thinning and replacement by new tissue. Too-fast degradation collapses mechanical support; too-slow degradation triggers chronic inflammation and blocks new-bone maturation.

Real-world applications

Craniofacial bone reconstruction: For cranial defects caused by trauma or tumour resection, deproteinised bovine bone (Geistlich Bio-Oss) and synthetic HA/BCP ceramic scaffolds are widely used. The skull carries little load but recovers shape, so 75-80% porosity and 300-500 μm pores are typical, with replacement by new bone targeted at 6-12 months. 3D printing makes patient-specific custom scaffolds increasingly mainstream.

Orthopaedic implants (hip stems, spinal cages): Porous titanium structures such as Stryker's Tritanium and Zimmer's Trabecular Metal (porous tantalum) are used in joint replacements and intervertebral cages. At 60-70% porosity their stiffness lands close to cortical bone (10-20 GPa), keeping stress shielding low while promoting bony ingrowth. Voronoi/TPMS (Gyroid, Schwarz) lattices fabricated by EBM/SLM are state of the art.

Dental implants and alveolar ridge reconstruction: To counter alveolar ridge resorption after extraction, porous β-TCP, HA/collagen composites and similar materials are used. Dental loads are relatively small, so softer scaffolds (above 80% porosity) work well. The technique is usually combined with guided bone regeneration (GBR), where a membrane blocks soft-tissue ingrowth while bone forms inside the scaffold.

Biodegradable scaffolds and drug release: Biodegradable polymers such as PHBV, PCL and PLGA can carry and slowly release BMP-2 (bone morphogenetic protein) or VEGF (angiogenic factor) to further boost cell activity. The vascularization-rate slider here is a simplified model of that effect, and combined with ε > 0.5 it gives a meaningful vascular index. Bioactive Glass (45S5) directly drives bone formation through ionic dissolution and is in clinical use as PerioGlas in dentistry.

Common misconceptions and pitfalls

The most common mistake is to assume "more porosity is always better". 70-85% really is required for vascular invasion, but Gibson-Ashby E_eff = E_s·(1-ε)² means going from ε=0.85 to 0.95 cuts E_eff by a factor of (0.15)²/(0.05)² = 9. For trabecular bone (E=0.4 GPa) that may still be acceptable; for cortical bone or any load-bearing site, scaffolds above 90% porosity crush on implantation and the mechanical microenvironment that drives osteogenesis (mechanotransduction) is lost. The upper bound on porosity is always set by the load case.

Second, "bigger pores let more vessels in". Below 100 μm vessels really cannot enter, but above 500 μm specific surface area drops, the initial fibrin clot is not retained inside the pores and cells fail to colonise. Large pores also weaken the scaffold significantly. The ideal is a bimodal structure: a 300-400 μm main pore network with a 20-50 μm micropore overlay, so cell attachment and mass transport coexist. Deliberately engineering this hierarchy with 3D printing or freeze-drying is a current research trend.

Finally, "Gibson-Ashby is a universal law". The E_eff = E_s·(1-ε)² used here is an idealised open-cell approximation and only agrees with real materials to roughly ±30%. Wall thickness scatter, pore morphology (spherical / columnar / TPMS), process defects (sintered cracks, unmelted powder in SLM) and hydration state (biodegradable polymers soften significantly on hydrolysis) all shift the actual values. Use this tool for first-pass design, then verify with mechanical testing (e.g. ASTM D695 compression) and in vivo evaluation. It is a design-stage screening tool, not a replacement for experiments.

How to Use

  1. Select scaffold material (PLLA, PCL, or HA-composite) from the dropdown menu
  2. Set porosity percentage (60–90%) using the slider; higher porosity increases permeability but reduces effective modulus
  3. Define pore size (50–500 μm) and strut diameter (10–100 μm) to control cell migration pathways and mechanical load-bearing
  4. Specify degradation timeline (2–24 weeks) to simulate resorption matching bone regeneration kinetics
  5. Review output metrics: effective modulus alignment with trabecular bone (8–20 GPa target), compressive strength match (2–12 MPa), and permeability coefficient for nutrient diffusion

Worked Example

Design a PCL scaffold for femoral head defect repair: Set porosity to 75%, pore size 200 μm, strut diameter 50 μm, degradation 12 weeks. Simulator returns effective modulus 4.2 GPa (88% bone match), compressive strength 5.8 MPa (92% bone match), permeability 2.1×10⁻⁹ m², and cell migration index 0.76. These values ensure mechanical support during early healing while permitting osteoblast infiltration and vascular ingrowth critical for osteointegration.

Practical Notes

  1. Strut diameter below 30 μm in PLLA scaffolds risks premature mechanical failure; use 40–60 μm for load-bearing applications in weight-bearing sites
  2. Pore sizes 100–150 μm favor bone ingrowth over cartilage; sizes above 300 μm increase fibrous encapsulation risk
  3. PCL degrades slower (16–24 weeks) than PLLA (8–12 weeks); match degradation rate to patient-specific healing trajectory
  4. Permeability below 1×10⁻¹⁰ m² causes hypoxic core regions; target 1–5×10⁻⁹ m² for nutrient delivery in 3–5 mm thick constructs